Bonum therapeutics融资
WebNov 15, 2024 · Company Type For Profit. Contact Email [email protected]. Phone Number 206.888.8485. Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary … WebNov 15, 2024 · Permission granted by Bonum Therapeutics. Two months ago, biotechnology startup Good Therapeutics struck it big. A cancer immunotherapy the company was working on drew such interest from Roche that the Swiss pharmaceutical giant paid $250 million, far more than the $30 million the startup had raised privately, to …
Bonum therapeutics融资
Did you know?
WebNov 15, 2024 · Courtesy of Getty Images. Three months after selling an immuno-oncology platform developed by Good Therapeutics to Roche, founder John Mulligan launched Bonum Therapeutics Tuesday with $93 million in Series A financing.. Bonum was … WebSep 8, 2024 · On concluding the deal, the Good Therapeutics team intends to leverage its technology to design conditionally active therapies for other immuno-oncology targets and further in a new firm, Bonum Therapeutics. Roche Pharma Partnering global head James Sabry said: “We are excited to bring Good’s innovative PD-1-regulated IL-2 programme …
WebSep 7, 2024 · With this acquisition, Roche will gain rights to Good Therapeutics’ innovative, conditionally active, PD-1-regulated IL-2 program and an exclusive right to the platform technology for the ... WebNov 15, 2024 · Bonum is a spinout of Good Therapeutics, which Roche acquired in August 2024 for $250 million upfront plus potential milestone payments. The investor syndicate that financed Good Therapeutics ...
WebFeb 27, 2024 · Senior Scientist at Bonum Therapeutics . Sandra Notonier is a Senior Scientist at Bonum Therapeutics based in Seattle, Washington. Previously, Sandra was a Scientist at Good Therapeutics and also held positions at SystImmune, Department of Energy - National Renewable Energy Laboratory, GCxN, University of Stuttgart, … WebMar 30, 2024 · Four years ago, I joined Bonum Therapeutics' predecessor, Good Therapeutics, fascinated by the mechanistic concept developed by Founder and CEO John Mulligan. He envisioned an antibody-cytokine ...
Web哪里可以找行业研究报告？三个皮匠报告网的最新栏目每日会更新大量报告，包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新，通过最新栏目，大家可以快速找到自己想要的内容。
WebNov 15, 2024 · Bonum Therapeutics has raised a total of $93M in funding over 1 round. This was a Series A round raised on Nov 15, 2024. Bonum Therapeutics is funded by 6 investors. Roche Venture Fund and Digitalis Ventures are the most recent investors. tennis fairfield countyWebNov 15, 2024 · SEATTLE--(BUSINESS WIRE)-- Bonum Therapeutics, a biopharmaceutical company using allosteric regulation to create conditionally active and less toxic medicines, today announced a $93 million Series A financing. Bonum is a spinout of Good … triad recycling tonawanda nyWebWhat is Bonum Health? Bonum Health is a digital health technology company. Our team combines compassion with technology to help people everywhere take control of their health. Our focus is on making healthcare accessible, affordable, and convenient for … tennis fairy meadowWebNov 17, 2024 · Seattle-based biotech Bonum Therapeutics has raised a $93 million Series A round. Bonum said the funding, announced Tuesday, will help the company advance its technology and find collaborators. tennis famele tennis coreanWebBonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines. Our Advantage. Our Science. We are creating a new class of regulated protein therapeutics designed to deliver potent … triad reserve center greensboro nctriad residential solutions grafton ohioWebAug 27, 2024 · 7、Kazia Therapeutics. 融资阶段：IPO. 临床进展：已获批上市. 具体情况：Kazia Therapeutics 是一家澳大利亚肿瘤学公司，致力于开发创新的、高影响力的癌症药物，主要资产 Paxalisib（原 GDC-0084）用于治疗胶质母细胞瘤。Paxalisib 是一种 PI3K 抑 … tennis fans stream